Dataset Information

A novel bioinformatics approach to identify the consistently well-performing normalization strategy for current metabolomic studies.

ABSTRACT: Unwanted experimental/biological variation and technical error are frequently encountered in current metabolomics, which requires the employment of normalization methods for removing undesired data fluctuations. To ensure the 'thorough' removal of unwanted variations, the collective consideration of multiple criteria ('intragroup variation', 'marker stability' and 'classification capability') was essential. However, due to the limited number of available normalization methods, it is extremely challenging to discover the appropriate one that can meet all these criteria. Herein, a novel approach was proposed to discover the normalization strategies that are consistently well performing (CWP) under all criteria. Based on various benchmarks, all normalization methods popular in current metabolomics were 'first' discovered to be non-CWP. 'Then', 21 new strategies that combined the 'sample'-based method with the 'metabolite'-based one were found to be CWP. 'Finally', a variety of currently available methods (such as cubic splines, range scaling, level scaling, EigenMS, cyclic loess and mean) were identified to be CWP when combining with other normalization. In conclusion, this study not only discovered several strategies that performed consistently well under all criteria, but also proposed a novel approach that could ensure the identification of CWP strategies for future biological problems.

SUBMITTER: Yang Q

PROVIDER: S-EPMC7711263 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

A novel bioinformatics approach to identify the consistently well-performing normalization strategy for current metabolomic studies.

Yang Qingxia Q Hong Jiajun J Li Yi Y Xue Weiwei W Li Song S Yang Hui H Zhu Feng F

Briefings in bioinformatics 20201201 6

Unwanted experimental/biological variation and technical error are frequently encountered in current metabolomics, which requires the employment of normalization methods for removing undesired data fluctuations. To ensure the 'thorough' removal of unwanted variations, the collective consideration of multiple criteria ('intragroup variation', 'marker stability' and 'classification capability') was essential. However, due to the limited number of available normalization methods, it is extremely ch ...[more]

PMID: 31776543

Similar Datasets

Project description:ImportanceThere has been a growth in the use of performance-based payment models in the past decade, but inherently noisy and stochastic quality measures complicate the assessment of the quality of physician groups. Examining consistently low performance across multiple measures or multiple years could potentially identify a subset of low-quality physician groups.ObjectiveTo identify low-performing physician groups based on consistently low performance after adjusting for patient characteristics across multiple measures or multiple years for 10 commonly used quality measures for diabetes and cardiovascular disease (CVD).Design, setting, and participantsThis cross-sectional study used medical and pharmacy claims and laboratory data for enrollees ages 18 to 65 years with diabetes or CVD in an Aetna health insurance plan between 2016 and 2019. Each physician group's risk-adjusted performance for a given year was estimated using mixed-effects linear probability regression models. Performance was correlated across measures and time, and the proportion of physician groups that performed in the bottom quartile was examined across multiple measures or multiple years. Data analysis was conducted between September 2020 and May 2021.ExposuresPrimary care physician groups.Main outcomes and measuresPerformance scores of 6 quality measures for diabetes and 4 for CVD, including hemoglobin A1c (HbA1c) testing, low-density lipoprotein testing, statin use, HbA1c control, low-density lipoprotein control, and hospital-based utilization.ResultsA total of 786 641 unique enrollees treated by 890 physician groups were included; 414 655 (52.7%) of the enrollees were men and the mean (SD) age was 53 (9.5) years. After adjusting for age, sex, and clinical and social risk variables, correlations among individual measures were weak (eg, performance-adjusted correlation between any statin use and LDL testing for patients with diabetes, r = -0.10) to moderate (correlation between LDL testing for diabetes and LDL testing for CVD, r = .43), but year-to-year correlations for all measures were moderate to strong. One percent or fewer of physician groups performed in the bottom quartile for all 6 diabetes measures or all 4 cardiovascular disease measures in any given year, while 14 (4.0%) to 39 groups (11.1%) were in the bottom quartile in all 4 years for any given measure other than hospital-based utilization for CVD (1.1%).Conclusions and relevanceA subset of physician groups that was consistently low performing could be identified by considering performance measures across multiple years. Considering the consistency of group performance could contribute a novel method to identify physician groups most likely to benefit from limited resources.

Dataset Information

A novel bioinformatics approach to identify the consistently well-performing normalization strategy for current metabolomic studies.

Publications

A novel bioinformatics approach to identify the consistently well-performing normalization strategy for current metabolomic studies.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets